CDMO
Resources

CDMO Resources

Partnering with CDMOs to advance cell and gene therapy

Reliable solutions for scalable, high-quality manufacturing. At BioLife Solutions, we understand the unique challenges Contract Development and Manufacturing Organizations (CDMOs) face in scaling cell and gene therapy production. Our best-in-class biopreservation, cell processing, and storage solutions are designed to support CDMOs at every stage—from early development to commercial manufacturing.

Our solutions for CDMOs

Biopreservation and cell expansion media

Cell processing and handling tools

Cryogenic storage and transport solutions

Why partner with us?

While GMP is not required for IND submissions, expectations scale from early IND through approval applications, and having a robust, repeatable manufacturing process can streamline regulatory approvals. GMP becomes mandatory for BLA submissions, ensuring that biologics are consistently produced and controlled to meet quality standards.

We have helped many customers navigate IND and BLA submissions successfully.

We provide expert advisory services to support customer process development, from cell manipulation to integrating GMP compliance into bioproduction workflows.

The BioLife portfolio of innovation offers solutions designed for both clinical and commercial manufacturing.

BioLife’s developments are supported by scientific data and industry-leading quality controls.

Our current CDMO partnerships

From supporting process development to supplying high-quality ancillary materials, BioLife Solutions partners with several active CDMOs. 

Here is a sample list of our partners:

Notch-Right-25px
Notch-Bottom-25px

Let’s build the future of cell and gene therapy together

Partner with a trusted supplier committed to supporting CDMOs with high-quality, scalable solutions. Contact us today to learn how we can enhance your manufacturing workflows.

This website uses cookies to ensure you get the best experience on our website.